Genesys board to meet on Jun 26 to consider fund raising
Genesys International Corporation Ltd will hold a board meeting on June 26, 2026, to consider raising funds through the issuance of securities. The trading window for designated persons closes on June 23, 2026, and will reopen 48 hours after the meeting concludes.

*this image is generated using AI for illustrative purposes only.
Genesys International Corporation Ltd has scheduled a board meeting for June 26, 2026, to evaluate a proposal for raising funds through the issuance of securities. The company aims to utilize permissible securities under applicable laws to secure capital, a move that could significantly impact its financial structure and future operations.
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting will address this strategic financial initiative. The specific instruments and the quantum of funds to be raised will be determined by the Board during this session.
In conjunction with the board meeting, the company has announced the closure of its trading window. Effective from June 23, 2026, designated persons and their relatives are prohibited from dealing in the company's securities. This restriction will remain in place until 48 hours after the conclusion of the Board Meeting, in compliance with the Insider Trading Code of Conduct and the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
The intimation regarding this meeting has been disseminated to BSE Limited and National Stock Exchange of India Ltd. The official notice is also accessible on the company's website at www.igenesys.com .
Key Meeting Details
| Detail | Information |
|---|---|
| Meeting Date | June 26, 2026 |
| Agenda | Fund raising via securities |
| Trading Window Closure | June 23, 2026 |
| Trading Window Reopens | 48 hours after meeting conclusion |
Historical Stock Returns for Genesys International Corp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -8.30% | -6.74% | +17.70% | -28.24% | -48.71% | +179.06% |
What specific instruments (e.g., equity, debt, convertible bonds) is the company likely to favor to optimize its capital structure?
How does the company intend to allocate the newly raised capital to drive future growth or operational expansion?
What impact could the dilution of equity or increased debt load have on existing shareholder value?

































